Aug 2026
Impact of adjuvant hormone therapy on cardiac function and lipid profiles in breast cancer patients: a prospective cohort study
It is suggested that HT-induced dyslipidaemia may contribute to subclinical cardiac dysfunction, highlighting the need for proactive CV monitoring and metabolic management in this population of breast cancer patients.
H. Park, N. Lee, J. E. Choi et al.
· European Heart Journal, Supp... · 0 citations